← All trials
NCT07306702
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2023
- Primary completion
- May 30, 2024
- Completion date
- Jun 2, 2024
- First posted
- Dec 29, 2025
- Last posted
- Dec 29, 2025
- Enrollment
- 102
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shenyang Sixth People's HospitalLead sponsor
- Shenyang Sixth People's HospitalSponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.